BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20507381)

  • 1. What's new in blistering diseases.
    Shimizu H
    J Dermatol; 2010 Mar; 37(3):193. PubMed ID: 20507381
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis therapy of pemphigus and bullous pemphigoid.
    Roujeau JC
    Semin Dermatol; 1988 Sep; 7(3):195-200. PubMed ID: 3153444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corticoids and plasma exchange in autoimmune bullous dermatoses].
    Roujeau JC; Marchesseau P; André C; Touzet C
    Ann Med Interne (Paris); 1986; 137 Suppl():11-4. PubMed ID: 3545005
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating consensus research goals and treatment strategies for pemphigus and pemphigoid: The 2010 JC Bystryn Pemphigus and Pemphigoid Meeting.
    Schultz HY; Diaz LA; Sirois DA; Werth VP; Grando SA
    J Invest Dermatol; 2011 Jul; 131(7):1395-9. PubMed ID: 21673705
    [No Abstract]   [Full Text] [Related]  

  • 9. Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332.
    Jedlickova H; Niedermeier A; Zgažarová S; Hertl M
    Dermatology; 2011; 222(3):193-5. PubMed ID: 21228551
    [No Abstract]   [Full Text] [Related]  

  • 10. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid.
    Eming R; Sticherling M; Hofmann SC; Hunzelmann N; Kern JS; Kramer H; Pfeiffer C; Schuster V; Zillikens D; Goebeler M; Hertl M; Nast A; Orzechowski HD; Sárdy M; Schmidt E; Sitaru C; Sporbeck B; Worm M
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):833-44. PubMed ID: 26213827
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological therapy of autoimmune blistering diseases.
    Alaibac M
    Expert Opin Biol Ther; 2019 Feb; 19(2):149-156. PubMed ID: 30558452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three blistering diseases. Why proper management is critical.
    Wooldridge WE
    Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid and pemphigus vulgaris.
    Patel HP; Anhalt GJ; Diaz LA
    Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
    [No Abstract]   [Full Text] [Related]  

  • 16. The desmosome and hemidesmosome in cutaneous autoimmunity.
    Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
    Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
    Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new in bullous pemphigoid.
    Ujiie H; Shibaki A; Nishie W; Shimizu H
    J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous diseases of childhood.
    Gellis SE
    Dermatol Clin; 1986 Jan; 4(1):89-98. PubMed ID: 3521982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma exchange in pemphigus vulgaris].
    Hunziker T; Schwarzenbach HR; Krebs A; Nydegger UE; Camponovo F; Hess M
    Schweiz Med Wochenschr; 1981 Oct; 111(44):1637-42. PubMed ID: 7302547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.